Literature DB >> 20451553

Chemokine receptors intracellular trafficking.

Elena M Borroni1, Alberto Mantovani, Massimo Locati, Raffaella Bonecchi.   

Abstract

Chemokines coordinate leukocyte recruitment during inflammatory and immune responses through the interaction with a distinct subfamily of G protein-coupled receptors. The magnitude of the cellular response elicited by chemokines is dictated by the level of receptor expression at the plasma membrane, which is the balance of finely tuned endocytic and recycling pathways. Recent data have revealed that receptor trafficking properties can drive chemokine receptors to lysosomal degradation or recycling pathways, producing opposite effects on the strength of the intracellular signaling cascade. This review will cover recent advances on the molecular mechanisms underlying chemokine receptor internalization, recycling and degradation pathways, with particular attention to structural motifs present in receptor intracellular domains and their interacting adaptor proteins that modulate receptor trafficking and dictate proper biological response. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451553     DOI: 10.1016/j.pharmthera.2010.04.006

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  36 in total

Review 1.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.

Authors:  Shumei Man; Barbara Tucky; Anne Cotleur; Judith Drazba; Yukio Takeshita; Richard M Ransohoff
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

3.  Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.

Authors:  Masahiko Uchida; Tetsuhide Ito; Taichi Nakamura; Masayuki Hijioka; Hisato Igarashi; Takamasa Oono; Masaki Kato; Kazuhiko Nakamura; Koichi Suzuki; Ryoichi Takayanagi; Robert T Jensen
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

Review 4.  CXCL12 signaling in the development of the nervous system.

Authors:  Divakar S Mithal; Ghazal Banisadr; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-21       Impact factor: 4.147

5.  De novo characterization of the liver transcriptome of javelin goby Synechogobius hasta and analysis of its transcriptomic profile following waterborne copper exposure.

Authors:  Qi-Liang Chen; Zhi Luo; Chao Huang; Ya-Xiong Pan; Kun Wu
Journal:  Fish Physiol Biochem       Date:  2015-12-30       Impact factor: 2.794

6.  Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration.

Authors:  Sarah Straschewski; Marco Patrone; Paul Walther; Andrea Gallina; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  RNA-Seq Profile Reveals Th-1 and Th-17-Type of Immune Responses in Mice Infected Systemically with Aspergillus fumigatus.

Authors:  Jata Shankar; Gustavo C Cerqueira; Jennifer R Wortman; Karl V Clemons; David A Stevens
Journal:  Mycopathologia       Date:  2018-03-02       Impact factor: 2.574

8.  Regulation of C-C chemokine receptor 5 (CCR5) stability by Lys197 and by transmembrane protein aptamers that target it for lysosomal degradation.

Authors:  Lisa M Petti; Sara A Marlatt; Yong Luo; Elizabeth H Scheideman; Ashish Shelar; Daniel DiMaio
Journal:  J Biol Chem       Date:  2018-04-20       Impact factor: 5.157

Review 9.  Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.

Authors:  Knut Liseth; Elisabeth Ersvaer; Tor Hervig; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2010-06-02

10.  The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease.

Authors:  Josh M Morganti; Kevin R Nash; Bethany A Grimmig; Sonali Ranjit; Brent Small; Paula C Bickford; Carmelina Gemma
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.